This commercially available antibody is directed against a protein of the endoplasmic reticulum. It is a sensitive marker for plasma cells. Positive staining is seen in plasma cell, plasmablasts, lymphoplasmacytoid cells, and B-immunoblasts. However, positivity has been reported in other tumours, including melanocytic lesions, neuroendocrine tumours and many epithelial tumours.
Adv Anat Pathol 1997;4:332.
Shanks JH, Banerjee SS. VS38 immunostaining in melanocytic lesions. J Clin Pathol 1996:49;205-7.
©SMUHT/PW Bishop